Duration of Use by Long-Acting Reversible Contraceptive Method, Nampula and Sofala Provinces, Mozambique, December 2018–May 2019
| Duration of Use | Nampula, No. (%) | Sofala, No. (%) | Total, No. (%) |
|---|---|---|---|
| One-rod etonogestrel (n=19) | |||
| Within first 3 months | 6 (66.7) | 2 (20.0) | 8 (42.1) |
| Before expiration | 3 (33.3) | 7 (70.0) | 10 (52.6) |
| On schedule/expired (33–36 months) | 0 (0) | 0 (0) | 0 (0) |
| After expiration | 0 (0) | 1 (10.0) | 1 (5.3) |
| Two-rod levonorgestrel implant (n=576) | |||
| Within first 3 months | 29 (11.7) | 28 (8.5) | 57 (9.9) |
| Before expiration | 179 (72.5) | 259 (78.7) | 438 (76.0) |
| On schedule/expired (57–60 months) | 17 (6.9) | 20 (6.1) | 37 (6.4) |
| After expiration | 22 (8.9) | 22 (6.7) | 44 (7.6) |
| Intrauterine device (copper) (n=66) | |||
| Within first 3 months | 14 (37.8) | 2 (6.9) | 16 (24.2) |
| Before expiration | 21 (56.8) | 27 (93.1) | 48 (72.7) |
| On schedule/expired (117–120 months) | 0 (0) | 0 (0) | 0 (0) |
| After expiration | 2 (5.4) | 0 (0) | 2 (3.0) |
| All methods (n=661) | |||
| Within first 3 months | 49 (16.7) | 32 (8.7) | 81 (12.3) |
| Before expiration | 203 (69.3) | 293 (79.6) | 496 (75.0) |
| On schedule/expired | 17 (5.8) | 20 (5.4) | 37 (5.6) |
| After expiration | 24 (8.2) | 23 (6.3) | 47 (7.1) |